US$ 29.70
can glp 1 hurt your kidneys Glucagon-like Peptide Receptor Agonists and Kidney Outcomes in the Era of Personalized Medicine: Focus on Albuminuria Both SGLT2 and GLP-1 Drugs
Description
Value Based Care Group

Wegovy is designed as a once-weekly injection, but many patients wonder if more frequent dosing could work

Retrospectively registered, 8 October 2021.
Clinicians should maintain heightened awareness for aspiration risk in perioperative settings

Its primary outcomes measure is time to first occurrence of any component event of a composite endpoint comprising all-cause death, non-fatal myocardial infarction, non-fatal stroke, coronary revascularization, or heart failure events that result in hospitalization or urgent hospital visits
